Many countries around the globe are struggling with the pricing of Gilead Sciences’ new Hepatits C drug, Sovaldi, but France has come up with an entirely new strategy – taxes! The French government has said it plans on taxing drug makers whose pricey hepatitis C treatments pose an undue burden on its healthcare system. See here for more details on this decision. (Source: FiercePharma, 10/1/14).
You are here: / / Watch out Gilead – France Has A New Tax In Town!